SV2A - synaptic vesicle glycoprotein 2A Gene

Species: Felis catus

Gene Type: protein coding
Gene ID: 101081564

SV2A Products (4)

mRNA Protein Name
XM_045033446.1 XP_044889381.1 synaptic vesicle glycoprotein 2A isoform X2
XM_003990559.6 XP_003990608.1 synaptic vesicle glycoprotein 2A isoform X1
XM_045033448.1 XP_044889383.1 synaptic vesicle glycoprotein 2A isoform X3
XM_045033447.1 XP_044889382.1 synaptic vesicle glycoprotein 2A isoform X3
Protein Preferred Names Protein Names

synaptic vesicle glycoprotein 2A

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-B0106 Levetiracetam Inhibitor 99.98% Unkown

Clinical Phase

Bioactive Molecules (3)
Cat. No. Product Name Effect
Purity Phase
HY-119810 Seletracetam Modulator 99.70% Phase 3
HY-119810B Seletracetam lithium bromide Modulator / Phase 3
HY-136873 UCB-J Ligand 99.62% Phase 2

Pre-clinical Phase

Bioactive Molecules (11)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-157999 SDI-118 Modulator 98.86% Unkown
HY-167830 SDM-8 99.79% Unkown
HY-180554 UCB1244283 Modulator / Unkown
HY-136873A (Rac)-UCB-J Ligand / Unkown
HY-176866 Rodin-A Inhibitor / Unkown
HY-176867 Rodin-B Inhibitor / Unkown
HY-B0106S Levetiracetam-d6 Inhibitor / Unkown
HY-RS14054 SV2A Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-B0106S1 Levetiracetam-d3 Inhibitor / Unkown
HY-RS16880 Sv2a Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS23322 Sv2a Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
Bioactive MoleculesInhibitory Antibodies (1)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-119810A Seletracetam lithium / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens SV2A NCBI NCBI:9900